Use of measles-mumps-rubella (MMR) vaccine for the management of mumps outbreaks in Canada. : HP40-286/2024E-PDF
"This Statement provides an evidence summary and recommendations on the topic of additional dose(s) of MMR vaccine provided in mumps outbreak settings, including the off-label administration of a third dose of MMR vaccine (MMR3) in individuals who were previously vaccinated with two valid doses, for consideration by public health programs"--Page 4.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.937672&sl=1
| Ministère/Organisme | Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. |
|---|---|
| Titre | Use of measles-mumps-rubella (MMR) vaccine for the management of mumps outbreaks in Canada. |
| Type de publication | Monographie |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Édition précédente | Use of measles-mumps-rubella (MMR) vaccine for the management of mumps outbreaks in Canada. [July 2021 edition] |
| Format | Électronique |
| Document électronique | |
| Note(s) | Cover title. "Revised publication: 2024." Issued also in French under title: Utilisation du vaccin contre la rougeole, la rubéole et les oreillons (RRO) pour la prise en charge des éclosions d'oreillons au Canada. At head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). "Notice to reader: The errors in the references have been corrected." Includes bibliographical references (pages 33-39). |
| Information sur la publication | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, 2024. ©2024 |
| Description | 1 online resource (54 pages) : graphs |
| ISBN | 9780660717234 |
| Numéro de catalogue |
|
| Numéro de catalogue du ministère | 240116 |
| Édition | [Revised 2024 edition]. |
| Descripteurs | Mumps -- Vaccination -- Canada. |